Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

FRANK SCIURBA

NPI
1285609545
CMS profile
13173
Location
PITTSBURGH, PA

General Payments · PY2018–2024

$91,674.37

  • Reported across 107 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$30,581.34

25 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Consulting Fee $27,840.00 7
Travel and Lodging $2,199.14 8
Food and Beverage $542.20 10

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
GlaxoSmithKline, LLC. $8,826.21 3
GENZYME CORPORATION $6,589.61 4
Genentech USA, Inc. $6,175.41 7
Pulmonx Corporation $4,586.81 5
Regeneron Pharmaceuticals, Inc. $4,315.10 5
Acerta Pharma LLC $88.20 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $9,306.97 24
PY2019 $8,312.89 9
PY2022 $10,611.63 18
PY2023 $32,861.54 31
PY2024 $30,581.34 25

Payment records · PY2024 (25)

Sorted by paying entity, then date · as published by CMS

Program year 2024 2018201920222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
AstraZeneca Pharmaceuticals LP $88.20 09/09/2024 Food and Beverage Undisputed 01/23/2026 1110539963 CMS
Genentech USA, Inc. $228.23 06/22/2024 Travel and Lodging Undisputed 01/23/2026 1133012257 CMS
Genentech USA, Inc. $7.46 06/22/2024 Food and Beverage Undisputed 01/23/2026 1133012261 CMS
Genentech USA, Inc. $11.50 06/22/2024 Food and Beverage Undisputed 01/23/2026 1133012265 CMS
Genentech USA, Inc. $385.03 06/22/2024 Travel and Lodging Undisputed 01/23/2026 1133012269 CMS
Genentech USA, Inc. $12.74 06/22/2024 Food and Beverage Undisputed 01/23/2026 1133012273 CMS
Genentech USA, Inc. $5,115.00 06/22/2024 Consulting Fee Undisputed 01/23/2026 1133012277 CMS
Genentech USA, Inc. $415.45 06/22/2024 Travel and Lodging Undisputed 01/23/2026 1133012282 CMS
GENZYME CORPORATION $284.28 08/16/2024 Food and Beverage Undisputed 01/23/2026 1139633685 CMS
GENZYME CORPORATION $292.67 08/16/2024 Travel and Lodging Undisputed 01/23/2026 1139633687 CMS
GENZYME CORPORATION $762.66 08/22/2024 Travel and Lodging Undisputed 01/23/2026 1139633705 CMS
GENZYME CORPORATION $5,250.00 08/22/2024 Consulting Fee Undisputed 01/23/2026 1139633707 CMS
GlaxoSmithKline, LLC. $5,525.00 07/19/2024 Consulting Fee Undisputed 01/23/2026 1116360084 CMS
GlaxoSmithKline, LLC. $51.21 09/10/2024 Food and Beverage Undisputed 01/23/2026 1116451403 CMS
GlaxoSmithKline, LLC. $3,250.00 12/18/2024 Consulting Fee Undisputed 01/23/2026 1116177267 CMS
Pulmonx Corporation $29.73 03/19/2024 Food and Beverage Undisputed 01/23/2026 1087850910 CMS
Pulmonx Corporation $45.79 05/21/2024 Food and Beverage Undisputed 01/23/2026 1087850912 CMS
Pulmonx Corporation $7.06 05/28/2024 Food and Beverage Undisputed 01/23/2026 1087850914 CMS
Pulmonx Corporation $4.23 08/13/2024 Food and Beverage Undisputed 01/23/2026 1087850916 CMS
Pulmonx Corporation $4,500.00 10/02/2024 Consulting Fee Undisputed 01/23/2026 1087850918 CMS
Regeneron Pharmaceuticals, Inc. $1,400.00 01/26/2024 Consulting Fee Undisputed 01/23/2026 1114404843 CMS
Regeneron Pharmaceuticals, Inc. $2,800.00 01/26/2024 Consulting Fee Undisputed 01/23/2026 1114404845 CMS
Regeneron Pharmaceuticals, Inc. $40.00 01/26/2024 Travel and Lodging Undisputed 01/23/2026 1114404847 CMS
Regeneron Pharmaceuticals, Inc. $37.00 01/26/2024 Travel and Lodging Undisputed 01/23/2026 1114404849 CMS
Regeneron Pharmaceuticals, Inc. $38.10 01/26/2024 Travel and Lodging Undisputed 01/23/2026 1114404851 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.